Alvotech and Dr. Reddy’s Laboratories have entered into a collaboration and licensing agreement to co-develop, manufacture, and commercialise a biosimilar of Keytruda (pembrolizumab) for global markets. Keytruda is widely used in the treatment of various cancers.
Comments
Post a Comment